Plato BioPharma
West Lafayette, US · Delaware corporation
Founders & leadership
RL
Robert Leasure, Jr.Named on SEC filing
BA
Beth A. TaylorNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$3M disclosed across 1 round · 2021
▶$3MraisedOct 2021 · 39 investors · Other Health CareRule 506(b)
▶$3MraisedOct 2021 · 39 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert Leasure, Jr.Executive Officer, Director
- Beth A. TaylorExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Plato BioPharma raised?
- Plato BioPharma has disclosed $3M raised across 1 round.
- Where is Plato BioPharma headquartered?
- Plato BioPharma is headquartered in West Lafayette, US.